Blog

Ruben Mesa and Srdan Verstovsek

Jan 14, 2025, 02:23

ASH2024 Insights from Ruben Mesa and Srdan Verstovsek

Peter Loffelhardt, Founder and CEO of Global MPN Scientific Foundation, shared a post on LinkedIn:

” Exclusive ASH2024 Insights from Prof. Ruben Mesa and Prof. Srdan Verstovsek!

This week, I had the honor of moderating an insightful discussion with two of the world’s leading experts in MPN research. Together, we explored the latest advancements and breakthroughs shaping the future of MPN care.

This session offered valuable perspectives for patients, caregivers, and healthcare professionals alike. Don’t miss the opportunity to gain exclusive insights into what’s ahead for MPN treatment and management.

Watch the full video now.”

ASH2024 cancer fight against cancer Global fight against cancer Global MPN Scientific Foundation MPN research OncoDaily Oncology Ruben Mesa Srdan Verstovsek

NEW PAPER ALERT: Efficacy of CDK4/6 Inhibitors and Endocrine Therapy in HR+/HER2- Advanced Breast Cancer by PAM50 Subtype: SOLTI-1801 CDK-PREDICT Results

Oncologist Near Me – Fabrice André: Leading Expert in Breast Cancer

Funding Impactful Cancer Research That Might Otherwise Go Unsupported: Ryan Schoenfeld on the Secret Behind Mark Foundation’s Success

One Hand Gives, Another Takes? Trump, Musk, Congress and Childhood Cancer Research Funding

Fabrice André has been elected as the President of the ESMO for the term 2025-2026

Special Coverage